Original articlesUrogenital tumorsCHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
Urogenital tumors
Under an Elsevier user license
open archive
Key words
chromatin remodeler CHD1
PCa
DDR
homologous recombination
non-homologous end joining
synthetic lethality
Cited by (0)
- †
Present address: Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore.
- ‡
These authors contributed equally as first authors.
Copyright © 2017 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.